BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 30030117)

  • 1. Tumor-infiltrating lymphocytes associate with outcome in nonendemic nasopharyngeal carcinoma: a multicenter study.
    Almangush A; Ruuskanen M; Hagström J; Hirvikoski P; Tommola S; Kosma VM; Nieminen P; Mäkitie A; Leivo I
    Hum Pathol; 2018 Nov; 81():211-219. PubMed ID: 30030117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of an individualized angiogenesis and tumor-infiltrating lymphocytes prognostic signature in nasopharyngeal carcinoma.
    Zhang R; Liao X; Zhang B; Huang X; Qin G; Kong X; Xie Y; Mo Y; Dai J; Gan C; Luo Z; Lu J; Jiang W
    Pathol Res Pract; 2024 Jan; 253():154936. PubMed ID: 38006840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Significance of Tumor-associated Stroma in Nasopharyngeal Carcinoma: A Multicenter Study.
    Almangush A; Ruuskanen M; Hagström J; Kosma VM; Nieminen P; Mäkitie AA; Leivo I
    Am J Surg Pathol; 2024 Jan; 48(1):54-58. PubMed ID: 37779503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating lymphocytes in oral cavity squamous cell carcinoma and its association with clinicopathological parameters.
    Ahuja S; Khan AA; Zaheer S; Ranga S
    Pathol Res Pract; 2023 Nov; 251():154882. PubMed ID: 37898039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional status and its correlation to prognosis of nasopharyngeal carcinoma patients in different ages in China: a multicenter cohort study.
    Jia P; Wu X; Shen F; Xu G; Xu H; Cong M; Song C; Shi H
    Support Care Cancer; 2023 Oct; 31(12):638. PubMed ID: 37847417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immune phenotype of tongue squamous cell carcinoma predicts early relapse and poor prognosis.
    Troiano G; Rubini C; Togni L; Caponio VCA; Zhurakivska K; Santarelli A; Cirillo N; Lo Muzio L; Mascitti M
    Cancer Med; 2020 Nov; 9(22):8333-8344. PubMed ID: 33047888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TCR repertoire profiling of tumors, adjacent normal tissues, and peripheral blood predicts survival in nasopharyngeal carcinoma.
    Jin YB; Luo W; Zhang GY; Lin KR; Cui JH; Chen XP; Pan YM; Mao XF; Tang J; Wang YJ
    Cancer Immunol Immunother; 2018 Nov; 67(11):1719-1730. PubMed ID: 30155576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infiltrating lymphocytes and accessory cells in nasopharyngeal carcinoma.
    Zong YS; Zhang CQ; Zhang F; Ruan JB; Chen MY; Feng KT; Yu ZF
    Jpn J Cancer Res; 1993 Aug; 84(8):900-5. PubMed ID: 8407554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic significance of race in nasopharyngeal carcinoma by histological subtype.
    Stepan KO; Mazul AL; Skillington SA; Paniello RC; Rich JT; Zevallos JP; Jackson RS; Pipkorn P; Massa S; Puram SV
    Head Neck; 2021 Jun; 43(6):1797-1811. PubMed ID: 33620125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Deep Learning-Based Assessment Pipeline for Intraepithelial and Stromal Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Carcinoma.
    Hamada K; Murakami R; Ueda A; Kashima Y; Miyagawa C; Taki M; Yamanoi K; Yamaguchi K; Hamanishi J; Minamiguchi S; Matsumura N; Mandai M
    Am J Pathol; 2024 Mar; ():. PubMed ID: 38537936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD3+T-lymphocyte infiltration is an independent prognostic factor for advanced nasopharyngeal carcinoma.
    Al-Rajhi N; Soudy H; Ahmed SA; Elhassan T; Mohammed SF; Khoja HA; Ghebeh H
    BMC Cancer; 2020 Mar; 20(1):240. PubMed ID: 32199452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, Epidemiological, Morphological, and Immunohistochemical Aspects of Nasopharyngeal Carcinoma-4-Year Retrospective Study in the Western Part of Romania.
    Marin MA; Closca RM; Marin A; Rakitovan M; Nicoara A; Poenaru M; Militaru M; Baderca F
    Diagnostics (Basel); 2024 Mar; 14(7):. PubMed ID: 38611634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An algorithm for standardization of tumor Infiltrating lymphocyte evaluation in head and neck cancers.
    Xirou V; Moutafi M; Bai Y; Nwe Aung T; Burela S; Liu M; Kimple RJ; Shabbir Ahmed F; Schultz B; Flieder D; Connolly DC; Psyrri A; Burtness B; Rimm DL
    Oral Oncol; 2024 May; 152():106750. PubMed ID: 38547779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision Medicine for Nasopharyngeal Cancer-A Review of Current Prognostic Strategies.
    Suryani L; Lee HPY; Teo WK; Chin ZK; Loh KS; Tay JK
    Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotypic and Gene Expression Analyses of the Inflammatory Microenvironment in High-Grade Oral Epithelial Dysplasia and Oral Lichen Planus.
    Flores-Hidalgo A; Phero J; Steward-Tharp S; Williamson M; Paquette D; Krishnan D; Padilla R
    Head Neck Pathol; 2024 Mar; 18(1):17. PubMed ID: 38456941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AI-Based Risk Score from Tumour-Infiltrating Lymphocyte Predicts Locoregional-Free Survival in Nasopharyngeal Carcinoma.
    Wibawa MS; Zhou JY; Wang R; Huang YY; Zhan Z; Chen X; Lv X; Young LS; Rajpoot N
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning explainability in nasopharyngeal cancer survival using LIME and SHAP.
    Alabi RO; Elmusrati M; Leivo I; Almangush A; Mäkitie AA
    Sci Rep; 2023 Jun; 13(1):8984. PubMed ID: 37268685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial architecture of regulatory T-cells correlates with disease progression in patients with nasopharyngeal cancer.
    Zhou F; Shayan G; Sun S; Huang X; Chen X; Wang K; Qu Y; Wu R; Zhang Y; Liu Q; Zhang J; Luo J; Shi X; Liu Y; Liang B; Li YX; Wang J; Yi J
    Front Immunol; 2022; 13():1015283. PubMed ID: 36439177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight into Classification and Risk Stratification of Head and Neck Squamous Cell Carcinoma in Era of Emerging Biomarkers with Focus on Histopathologic Parameters.
    Mäkitie AA; Agaimy A; Almangush A
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428607
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.